15 Patents
- US124350342025Process of Preparing 3-fluoro-5(((1r,2ar)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1h-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
NIKANG THERAPEUTICS, Inc.
0 cites - US124157792025Processes of Making 3-fluoro-5-(((1s,2ar)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1h-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and Polymorphs Thereof
NIKANG THERAPEUTICS, Inc.
0 cites - US124101902025Condensed Heterocyclic Derivates as BCL-2 Inhibitors for the Treatment of Neoplastic Diseases
Newave Pharmaceutical Inc.
0 cites - US123916422025Tetrahydro-1h-cyclopenta[cd]indene Derivatives as Hypoxia Inducible Factor-2(alpha) Inhibitors
Nikang Therapeutics, Inc.
0 cites - US123310262025Sulfonamido Derivatives as Cyclin-dependent Kinase 2 Inhibitors
Nikang Therapeutics, Inc.
0 cites - 0 cites
- US122641672025Fused Tricyclic Ring Derivatives as SRC Homology-2 Phosphate Inhibitors
NIKANG THERAPEUTICS, Inc.
0 cites - US1217174120242,3-dihydrobenzo[b]thiophene Derivatives as Hypoxia Inducible Factor-2(alpha) Inhibitors
Nikang Therapeutics, Inc.
0 cites - US120775062024Indane Derivatives as Hypoxia Inducible Factor-2(α) Inhibitors
Nikang Therapeutics, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- US117533662023Tetrahydro-1h-cyclopenta[cd]indene Derivatives as Hypoxia Inducible Factor-2(alpha) Inhibitors
NIKANG THERAPEUTICS, Inc.
0 cites - US116800722023Condensed Heterocyclic Derivates as BCL-2 Inhibitors for the Treatment of Neoplastic Diseases
Newave Pharmaceutical Inc.
0 cites - US116343822023Process of Preparing 3-fluoro-5(((1r,2ar)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1h-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
Nikang Therapeutics, Inc.
0 cites